Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 320 results found since Jan 2013.
Detection of Myocardial Infarction by Cardiac Magnetic Resonance in Embolic Stroke Related to First Diagnosed Atrial Fibrillation
Elevated troponin levels are found in a significant number of patients who are diagnosed with acute embolic stroke (AES) after first diagnosed atrial fibrillation (AF). These myocardial injuries, which are known as cardiocerebral infarction (CCI), are potentially caused by coronary embolism and correspond to simultaneous cardiac and cerebral embolisms. However, this severe condition remains poorly understood. In this prospective study, we aimed to investigate the prevalence and the cardiac magnetic resonance (CMR) characteristics of CCI.
Source: Journal of Stroke and Cerebrovascular Diseases - April 10, 2021 Category: Neurology Authors: Adrien Artus, Romain Didier, Margaux Blain, Pierre Comby, Thibault Leclercq, Hugo Debeaumarch é, Frédéric Ricolfi, Marianne Zeller, Yannick Bejot, Alexandre Cochet, Yves Cottin Source Type: research
Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin
In a previous real-world study, rivaroxaban reduced the risk of stroke overall and severe stroke compared with warfarin in patients with nonvalvular atrial fibrillation (NVAF). The aim of this study was to assess the reproducibility in a different database of our previously observed results (Alberts M, et al. Stroke. 2020;51:549-555) on the risk of severe stroke among NVAF patients in a different population treated with rivaroxaban or warfarin.
Source: Journal of Stroke and Cerebrovascular Diseases - March 17, 2021 Category: Neurology Authors: Dejan Milentijevic, Jennifer H. Lin, Nancy Connolly, Yen-Wen Chen, Emily Kogan, Shubham Shrivastava, Erik Sjoeland, Mark J. Alberts Source Type: research
Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy
About 15% of patients with non-valvular atrial fibrillation might require percutaneous coronary interventions (PCIs) with stent placement to treat obstructive coronary artery disease. Dual antiplatelet therapy (DAPT) with acetylsalicylic acid (aspirin) and P2Y12 antagonist is recommended after PCI. Patients requiring DAPT also require treatment with oral anticoagulation for atrial fibrillation. We conducted a meta-analysis to identify the antithrombotic regimen associated with the lowest rate of bleeding and thromboembolic events in non-valvular atrial fibrillation after PCI.
Source: Journal of Stroke and Cerebrovascular Diseases - February 9, 2021 Category: Neurology Authors: Aaron Desai, Cesar Escamilla-Ocanas, Deepika Dilip, Hamidreza Saber, Rahul Damani Source Type: research
The Proportion of Preventable Thrombectomy Procedures with Improved Atrial Fibrillation Stroke Prevention
Large vessel occlusion (LVO) strokes can in part be prevented with better atrial fibrillation (AF) stroke prevention strategies; thus we evaluated the rate of AF in patients presenting with acute LVO strokes undergoing mechanical thrombectomy (MT) and assessed patterns of oral anticoagulant (OAC) use prior to the index stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - February 3, 2021 Category: Neurology Authors: Nicole B. Sur, Vasu Saini, Luis F. Torres, Kunakorn Atchaneeyasakul, Amer M. Malik, Dileep R. Yavagal, Seemant Chaturvedi Source Type: research
Sex Differences in Management and Outcomes of Cardioembolic Stroke: Post HOC Analyses of the RELAXED Study
In this study, we examined sex differences as a post hoc analysis of RELAXED (Recurrent Embolism Lessened by rivaroxaban, an anti-X agent, of Early Dosing for acute IS and TIA with atrial fibrillation) Study.
Source: Journal of Stroke and Cerebrovascular Diseases - January 30, 2021 Category: Neurology Authors: Takashi Okada, Kazutaka Uchida, Fumihiro Sakakibara, Hiroto Kageyama, Masahiro Yasaka, Kazunori Toyoda, Etsuro Mori, Teruyuki Hirano, Toshimitsu Hamasaki, Hiroshi Yamagami, Takehiko Nagao, Shinichiro Uchiyama, Kazuo Minematsu, Shinichi Yoshimura, for the Source Type: research
Determination of Cerebrovascular Accident Predictors in Patients with New-Onset Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
Postoperative atrial fibrillation (POAF) is associated with an increased risk of short and long-term stroke. Our aim is to identify the independent predictors of cerebrovascular accident (CVA) development in the patients who underwent isolated coronary artery bypass graft (CABG) surgery and developed POAF which lasted within 48 h.
Source: Journal of Stroke and Cerebrovascular Diseases - January 12, 2021 Category: Neurology Authors: Ali Riza Demir, Omer Celik, Begum Uygur, Mustafa Umut Somuncu, Emre Yilmaz, Yalcin Avci, Muhammed Bayram, Mehmet Erturk Source Type: research
Malignant Left Atrial Appendage Morphology: Current Classification vs H-L System
In non-valvular atrial fibrillation (AF), more than 90% of thrombus formation occurs in the left atrial appendage (LAA).1-3 Current guidelines have established direct oral anticoagulants (DOACs) as the treatment of choice in patients with AF and high risk of stroke or transient ischemic attack (TIA), while vitamin K antagonists (VKA) can be considered in patients not suitable for DOACs.4,5 This strategy significantly reduces the risk of thromboembolism; however, there is a subset of patients that suffer recurrent embolic strokes despite appropriate anticoagulant therapy, known as malignant LAA.
Source: Journal of Stroke and Cerebrovascular Diseases - December 30, 2020 Category: Neurology Authors: Paloma Parra-D íaz, Luisa Salido-Tahoces, Ana Pardo-Sanz, Álvaro Beltrán-Corbellini, Fernando Rodríguez-Jorge, Juan Luis Chico-García, Sebastián García-Madrona, Consuelo Matute-Lozano, Rocío Vera-Lechuga, Antonio Cruz-Culebras, Jaime Masjuan, Alic Source Type: research
Insights Into Direct Oral Anticoagulant Therapy Implementation of Stroke Survivors with Atrial Fibrillation in an Ambulatory Setting
Atrial fibrillation (AF) is the most common cardiac arrhythmia and increases the risk of ischemic stroke by about five times.1 Oral anticoagulation (OAC) with direct oral anticoagulants (DOAC) or vitamin K antagonists (VKA) reduces ischemic stroke risk in AF patients. Currently, DOAC (apixaban, dabigatran, edoxaban and rivaroxaban) are recommended as first-line treatment for stroke prevention in AF patients.2 Despite several advantages compared to VKA, DOAC have a short half-life of about 12 h. Missing more than 5% of intakes is associated with a higher occurrence of thromboembolic events in OAC-treated AF patients.
Source: Journal of Stroke and Cerebrovascular Diseases - December 14, 2020 Category: Neurology Authors: Valerie Albert, Alexandros A. Polymeris, Fine Dietrich, Stefan T. Engelter, Kurt E. Hersberger, Sabine Schaedelin, Philippe A. Lyrer, Isabelle Arnet Source Type: research
Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation
Guidelines for the primary prevention of stroke recognize the emergency department as a location for physicians to identify atrial fibrillation and to initiate oral anticoagulants. Numerous studies have shown low anticoagulant prescription rates —approximately 18%—in OAC-naïve patients with atrial fibrillation discharged from the emergency department. We sought to obtain the opinions of Emergency Medicine physicians regarding anticoagulant decision-making for patients with atrial fibrillation seen in the emergency department.
Source: Journal of Stroke and Cerebrovascular Diseases - November 24, 2020 Category: Neurology Authors: Hope Hua, Nicole Sur, Lilly Lee, Seemant Chaturvedi Source Type: research
Left Atrial Spinning Ball Thrombus in a Patient with Cardioembolic Stroke: A Case Report
Left atrial thrombi are found in 2.5 –18% of patients with atrial fibrillation and are the main cause of thromboembolic events.1 Abe et al advocated the classification of left atrial thrombi into three types; movable ball type, fixed ball type and mountain type, and demonstrated that the rate of embolism in the movable type group wa s significantly higher than that in the other groups.2,3 However, there is no previous report that specifically describes what kind of movement has a poor prognosis in movable left atrial thrombi.
Source: Journal of Stroke and Cerebrovascular Diseases - October 3, 2020 Category: Neurology Authors: Akira Machida, Yasuhito Kawana, Itsuki Soejima, Takeshi Bo, Eiichiro Amano Tags: Case Report Source Type: research
Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey
We sought to understand practice patterns in management of patients who have ischemic stroke while adherent to oral anticoagulation for non-valvular atrial fibrillation (NVAF) in the United States (US).
Source: Journal of Stroke and Cerebrovascular Diseases - September 11, 2020 Category: Neurology Authors: Setareh Salehi Omran, Neal S. Parikh, Maria Zambrano Espinoza, Mackenzie P. Lerario, Steven R. Levine, Hooman Kamel, Randolph Marshall, Joshua Willey Source Type: research
Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation
Oral anticoagulation (OAC) substantially reduces stroke risk in patients with atrial fibrillation (AF) at risk for stroke. Whether non-vitamin K-dependent oral anticoagulants (NOACs) improve OAC use in stroke prevention requires investigation.
Source: Journal of Stroke and Cerebrovascular Diseases - September 10, 2020 Category: Neurology Authors: Simon Hellwig, Ulrike Grittner, Juliane Herm, Rudi Ruschmann, Maria Konieczny, Matthias Endres, Karl Georg Haeusler Source Type: research
Stroke-Related Visual Impairment; is There an Association with Atrial Fibrillation?
This study explores whether presence of visual impairment following stroke is associated with presence of atrial fibrillation (AF).
Source: Journal of Stroke and Cerebrovascular Diseases - August 23, 2020 Category: Neurology Authors: Fiona J Rowe, Lauren R Hepworth, Claire Howard, Claire Cullen, Benjamin Sturgess, Natalie Griffiths, Gregory Y H Lip Source Type: research
Prehospital continuous ECG is valuable for very early detection of atrial fibrillation in patients with acute stroke
Atrial fibrillation (AF) is a major risk factor for recurrent stroke and death in ischemic stroke patients.1,2 Due to its elusive nature AF often goes undetected.3 The use of continuous ECG (cECG) improves detection rates.4,5 Early detection, and therefore timely initiation of oral anticoagulant treatment may improve the prognosis after stroke.6 –8 In acute ischemic stroke patients guidelines recommend an admission in-hospital 12-lead ECG followed by at least 24 or 72 hours of continuous monitoring (American and European guidelines respectively).
Source: Journal of Stroke and Cerebrovascular Diseases - August 15, 2020 Category: Neurology Authors: Louise Feldborg Lyckhage, Morten Lock Hansen, Kristina Procida, Troels Wienecke Source Type: research
Predictors of atrial fibrillation detection and features of recurrent strokes in patients after cryptogenic stroke
Use of implantable cardiac monitors (ICMs) has increased diagnosis of atrial fibrillation (AF) in cryptogenic stroke (CS) patients. Identifying AF predictors may enhance the yield of AF detection. Recurrent strokes after CS are not well described. We aimed to assess the predictors for AF detection and the characteristics of recurrent strokes in patients after CS.
Source: Journal of Stroke and Cerebrovascular Diseases - August 15, 2020 Category: Neurology Authors: Jindong Xu, Pramod Sethi, Sharon Biby, James Allred, Amber Seiler, Rizwan Sabir Source Type: research
